Join Dr Adele Costabile at 8 pm UK time on the 8th of June
On the agenda
Cardiovascular disease is the number one cause of death globally, claiming 17.9 million lives each year. A major risk factor for the condition is elevated levels of low-density lipoprotein (LDL), colloquially referred to as "bad" cholesterol.
In light of this, researchers are constantly on the lookout for novel and cost-effective treatments to minimise heart disease risk factors, with probiotics emerging as a promising candidate.
Join Dr Adele Costabile as she explores the link between our microbiome and cholesterol levels, ultimately seeking to answer the question: Can probiotics reduce "bad cholesterol" via changes in the microbiome?
On the agenda
Cardiovascular disease is the number one cause of death globally, claiming 17.9 million lives each year. A major risk factor for the condition is elevated levels of low-density lipoprotein (LDL), colloquially referred to as "bad" cholesterol.
In light of this, researchers are constantly on the lookout for novel and cost-effective treatments to minimise heart disease risk factors, with probiotics emerging as a promising candidate.
Join Dr Adele Costabile as she explores the link between our microbiome and cholesterol levels, ultimately seeking to answer the question: Can probiotics reduce "bad cholesterol" via changes in the microbiome?
Our speaker
Associate Professor in Nutrition at the University of Roehampton and an Honorary Postdoctoral Research Fellow the the University Of Reading
Associate Professor in Nutrition at the University of Roehampton and an Honorary Postdoctoral Research Fellow the the University Of Reading. More
Dr Adele Costabile is an Associate Professor in Nutrition at the University of Roehampton. and an Honorary Postdoctoral Research Fellow the the University Of Reading.
Over a distinguished career spanning 14 years, Dr Costabile has been involved in numerous research projects. Her most recent research focuses on the gut microbiota as a therapeutic target for nutritional interventions, with a particular emphasis on the application of prebiotics and probiotics to treat gut-mediated disorders.
To access this webinar, enter your details and press "submit". We will email you the webinar link on the day of the event
To access this webinar, enter your details and press "submit". We will email you the webinar link on the day of the event
Sign up
To access this webinar, enter your details and press "submit". We will email you the webinar link on the day of the event
By pressing submit, you agree to receive future communications from Atlas Biomed
Soho Works, 72-74 Dean Street, London W1D 3SG, United Kingdom